Global surveillance of emerging SARS-CoV-2 variants

Mahmut Uludağ,Roberto Incitti,Xin Gao,Jonathan Heeney,Takashi Gojobori,Intikhab Alam

DOI: https://doi.org/10.2471/blt.22.289528

IF: 13.831

2024-06-04

Bulletin of the World Health Organization

Abstract:Bull World Health Organ . 2024 Jun 1;102(6):374-374A. doi: 10.2471/BLT.22.289528. NO

public, environmental & occupational health

What problem does this paper attempt to address?

Early Detection and Surveillance of the SARS-CoV-2 Variant BA.2.86 — Worldwide, July–October 2023

Anastasia S. Lambrou,Erin South,Eliza S. Ballou,Clinton R. Paden,James A. Fuller,Stephen M.,Deena M. Butryn,Ryan T. Novak,Sean D. Browning,Amy E. Kirby,Rory M. Welsh,Daniel M. Cornforth,Duncan R. MacCannell,Cindy R. Friedman,Natalie J. Thornburg,Aron J. Hall,Laura J. Hughes,Barbara E. Mahon,Demetre C. Daskalakis,Nirav D. Shah,Brendan R. Jackson,Hannah L. Kirking,Stephen M. Bart

DOI: https://doi.org/10.15585/mmwr.mm7243a2

2023-10-28

MMWR Morbidity and Mortality Weekly Report

Abstract:Early detection of emerging SARS-CoV-2 variants is critical to assessing risk, providing clear and timely communication messages, and coordinating public health action. CDC used a multicomponent surve

public, environmental & occupational health
Global landscape of SARS-CoV-2 genomic surveillance and data sharing

Zhiyuan Chen,Andrew S. Azman,Xinhua Chen,Junyi Zou,Yuyang Tian,Ruijia Sun,Xiangyanyu Xu,Yani Wu,Wanying Lu,Shijia Ge,Zeyao Zhao,Juan Yang,Daniel T. Leung,Daryl B. Domman,Hongjie Yu

DOI: https://doi.org/10.1038/s41588-022-01033-y

IF: 30.8

2022-03-28

Nature Genetics

Abstract:Abstract Genomic surveillance has shaped our understanding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. We performed a global landscape analysis on SARS-CoV-2 genomic surveillance and genomic data using a collection of country-specific data. Here, we characterize increasing circulation of the Alpha variant in early 2021, subsequently replaced by the Delta variant around May 2021. SARS-CoV-2 genomic surveillance and sequencing availability varied markedly across countries, with 45 countries performing a high level of routine genomic surveillance and 96 countries with a high availability of SARS-CoV-2 sequencing. We also observed a marked heterogeneity of sequencing percentage, sequencing technologies, turnaround time and completeness of released metadata across regions and income groups. A total of 37% of countries with explicit reporting on variants shared less than half of their sequences of variants of concern (VOCs) in public repositories. Our findings indicate an urgent need to increase timely and full sharing of sequences, the standardization of metadata files and support for countries with limited sequencing and bioinformatics capacity.

genetics & heredity
Genomic Surveillance for SARS-CoV-2 — China, September 26, 2022 to January 29, 2023

Shiwen Wang,Peihua Niu,Qiudong Su,Xiaozhou He,Jing Tang,Ji Wang,Yenan Feng,Cao Chen,Xiang Zhao,Zhixiao Chen,Wenling Wang,Zeyuan Yin,Yuchao Wu,Changcheng Wu,Lili Li,Aili Cui,Yan Zhang,Caiyun Long,Xiaoyu Yang,Zhongxian Zhang,Hong Bo,Wenbo Xu,,

DOI: https://doi.org/10.46234/ccdcw2023.026

2023-01-01

China CDC Weekly

Abstract:Introduction: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has generated 2,431 variants over the course of its global transmission over the past 3 years. To better evaluate the genomic variation of SARS-CoV-2 before and after the optimization of coronavirus disease 2019 (COVID-19) prevention and control strategies, we analyzed the genetic evolution branch composition and genomic variation of SARS-CoV-2 in both domestic and imported cases in China (the data from Hong Kong and Macau Special Administrative Regions and Taiwan, China were not included) from September 26, 2022 to January 29, 2023.Methods: Analysis of the number of genome sequences, sampling time, dynamic changes of evolutionary branches, origin, and clinical typing of SARS-CoV-2 variants submitted by 31 provincial-level administrative divisions (PLADs) and Xinjiang Production and Construction Corps (XPCC) was conducted to assess the accuracy and timeliness of SARS-CoV-2 variant surveillance.Results: From September 26, 2022 to January 29, 2023, 20,013 valid genome sequences of domestic cases were reported in China, with 72 evolutionary branches. Additionally, 1,978 valid genome sequences of imported cases were reported, with 169 evolutionary branches. The prevalence of the Omicron variants of SARS-CoV-2 in both domestic and imported cases was consistent with that of international epidemic variants.Conclusions: This study provides an overview of the prevalence of Omicron variants of SARS-CoV-2 in China. After optimizing COVID-19 prevention and control strategies, no novel Omicron variants of SARS-CoV-2 with altered biological characteristics or public health significance have been identified since December 1, 2022.

public, environmental & occupational health
Corrigendum To: Genomic Diversity of Severe Acute Respiratory Syndrome–Coronavirus 2 in Patients with Coronavirus Disease 2019

Zijie Shen,Yan Xiao,Lu Kang,Wentai Ma,Leisheng Shi,Li Zhang,Zhuo Zhou,Jing Yang,Jiaxin Zhong,Donghong Yang,Li Guo,Guoliang Zhang,Hongru Li,Yu Xu,Mingwei Chen,Zhancheng Gao,Jianwei Wang,Lili Ren,Mingkun Li

DOI: https://doi.org/10.1093/cid/ciab900

2020-01-01

Abstract:Background. A novel coronavirus (CoV), severe acute respiratory syndrome (SARS)-CoV-2, has infected >75 000 individuals and spread to >20 countries. It is still unclear how fast the virus evolved and how it interacts with other microorganisms in the lung. Methods. We have conducted metatranscriptome sequencing for bronchoalveolar lavage fluid samples from 8 patients with SARS-CoV-2, and also analyzed data from 25 patients with community-acquired pneumonia (CAP), and 20 healthy controls for comparison. Results. The median number of intrahost variants was 1-4 in SARS-CoV-2-infected patients, ranged from 0 to 51 in different samples. The distribution of variants on genes was similar to those observed in the population data. However, very few intrahost variants were observed in the population as polymorphisms, implying either a bottleneck or purifying selection involved in the transmission of the virus, or a consequence of the limited diversity represented in the current polymorphism data. Although current evidence did not support the transmission of intrahost variants in a possible person-to-person spread, the risk should not be overlooked. Microbiotas in SARS-CoV-2-infected patients were similar to those in CAP, either dominated by the pathogens or with elevated levels of oral and upper respiratory commensal bacteria. Conclusion. SARS-CoV-2 evolves in vivo after infection, which may affect its virulence, infectivity, and transmissibility. Although how the intrahost variant spreads in the population is still elusive, it is necessary to strengthen the surveillance of the viral evolution in the population and associated clinical changes.
Landscape of SARS-CoV-2 genomic surveillance, public availability extent of genomic data, and epidemic shaped by variants: a global descriptive study

Z. Chen,A. Azman,X. Chen,J. Zou,Y. Tian,R. Sun,X. Xu,Y. Wu,W. Lu,S. Ge,Z. Zhao,J. Yang,D. Leung,D. Domman,H. Yu

DOI: https://doi.org/10.1101/2021.09.06.21263152

2021-01-01

MedRxiv

Abstract:Background Genomic surveillance has shaped our understanding of SARS-CoV-2 variants, which have proliferated globally in 2021. Characterizing global genomic surveillance, sequencing coverage, the extent of publicly available genomic data coupled with traditional epidemiologic data can provide evidence to inform SARS-CoV-2 surveillance and control strategies. Methods We collected country-specific data on SARS-CoV-2 genomic surveillance, sequencing capabilities, public genomic data, and aggregated publicly available variant data. We divided countries into three levels of genomic surveillance and sequencing availability based on predefined criteria. We downloaded the merged and deduplicated SARS-CoV-2 sequences from multiple public repositories, and used different proxies to estimate the sequencing coverage and public availability extent of genomic data, in addition to describing the global dissemination of variants. Findings Since the start of 2021, the COVID-19 global epidemic clearly featured increasing circulation of Alpha, which was rapidly replaced by the Delta variant starting around May 2021 and reaching a global prevalence of 96.6% at the end of July 2021. SARS-CoV-2 genomic surveillance and sequencing availability varied markedly across countries, with 63 countries performing routine genomic surveillance and 79 countries with high availability of SARS-CoV-2 sequencing. Less than 3.5% of confirmed SARS-CoV-2 infections were sequenced globally since September 2020, with the lowest sequencing coverage in the WHO regions of Eastern Mediterranean, South East Asia, and Africa. Across different variants, 28-52% of countries with explicit reporting on variants shared less than half of their variant sequences in public repositories. More than 60% of demographic and 95% of clinical data were absent in GISAID metadata accompanying sequences. Interpretation Our findings indicated an urgent need to expand sequencing capacity of virus isolates, enhance the sharing of sequences, the standardization of metadata files, and supportive networks for countries with no sequencing capability.
COVID-19: Understanding the New Variants of Concern

Ke-Yan Loo,Vengadesh Letchumanan

DOI: https://doi.org/10.36877/pmmb.a0000282

2022-12-04

Progress In Microbes & Molecular Biology

Abstract:The novel coronavirus, SARS-CoV-2, part of the Coronaviridae family, was discovered in December 2019 in China. World Health Organization named it COVID-19 and by March 2020, it had spread worldwide, causing a global pandemic. Despite continuous efforts to prevent the spread of the virus, the virus seemed always to be a step ahead of humankind as it rapidly evolved to produce new variants. These variants have higher transmissibility than the original virus and were responsible for new waves of infections. The first variant was Alpha, followed by the discovery of Beta, Gamma, Delta, and Omicron, being the latest variant of concern. Although vaccines were distributed worldwide to reduce the severity of the disease when infected with SARS-CoV-2, the emergence of new variants raised doubts about the efficacy of the available vaccines. Studies showed a decrease in neutralizing antibodies during infection with XBB and BQ subvariants compared to infections caused by other variants. Fortunately, early evidence shows that the mRNA vaccines are still effective against the current circulating Omicron sublineages of the coronavirus. Nevertheless, continuous genomic surveillance of the coronavirus is still important to detect any new variants of concern to assess their potential to threaten public health. The efficacy of vaccines and treatment options available against the latest circulating variant of SARS-CoV-2 should also be periodically evaluated. This ensures that the treatment and vaccines used are safe and effective against the virus to protect the public from another health crisis.
Global Landscape of SARS-CoV-2 Genomic Surveillance, Public Availability Extent of Genomic Data, and Epidemic Shaped by Variants.

Hongjie Yu,Zhiyuan Chen,Andrew Azman,Xinhua Chen,Junyi Zou,Yuyang Tian,Ruijia Sun,Xiangyanyu Xu,Yani Wu,Wanying Lu,Shijia Ge,Zeyao Zhao,Juan Yang,Daniel Leung,Daryl Domman

DOI: https://doi.org/10.21203/rs.3.rs-927070/v1

2021-01-01

Abstract:Genomic surveillance has shaped our understanding of SARS-CoV-2 variants, which have proliferated globally in 2021.We collected country-specific data on SARS-CoV-2 genomic surveillance, sequencing capabilities, public genomic data from multiple public repositories, and aggregated publicly available variant data. Then, different proxies were used to estimate the sequencing coverage and public availability extent of genomic data, in addition to describing the global dissemination of variants. We found that the COVID-19 global epidemic clearly featured increasing circulation of Alpha since the start of 2021, which was rapidly replaced by the Delta variant starting around May 2021. SARS-CoV-2 genomic surveillance and sequencing availability varied markedly across countries, with 63 countries performing routine genomic surveillance and 79 countries with high availability of SARS-CoV-2 sequencing. We also observed a marked heterogeneity of sequenced coverage across regions and countries. Across different variants, 21-46% of countries with explicit reporting on variants shared less than half of their variant sequences in public repositories. Our findings indicated an urgent need to expand sequencing capacity of virus isolates, enhance the sharing of sequences, the standardization of metadata files, and supportive networks for countries with no sequencing capability.
Genomic epidemiology reveals early transmission of SARS-CoV-2 and mutational dynamics in Nanning, China

DeWu Bi,XiaoLu Luo,ZhenCheng Chen,ZhouHua Xie,Ning Zang,LiDa Mo,ZeDuan Liu,YanRong Lin,YaQin Qin,XiKe Tang,Lü Lin,YuanLi Wang,LiangLi Cao,FeiJun Zhao,JinAi Zhou,ShanQiu Wei,ShaoYong Xi,QiuYing Ma,JianYan Lin

DOI: https://doi.org/10.1016/j.heliyon.2023.e23029

IF: 3.776

2023-12-03

Heliyon

Abstract:Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants are a fatal pathogen resulting in substantial morbidity and mortality, and posing a great threat to human health with epidemics and pandemics. Methods: Next-generation sequencing (NGS) was performed to investigate the SARS-CoV-2 genomic characterization. Phylogenetic analysis of SARS-CoV-2 genomes was used to probe the evolutionary. Homology protein structure modelling was done to explore potential effect of the mutations. Results: The eighty genome sequences of SARS-CoV-2 obtained from the thirty-nine patients with COVID-19. A novel variant with mutation H625R concomitant with S50L in spike glycoprotein had been identified. Phylogenetic analysis revealed that SARS-CoV-2 variants belong to several distinct lineages. Homology modelling indicated that variant with mutation H625R and S50L increases flexibility of S1 subunit. Conclusions: SARS-CoV-2 genomes are constantly evolving by accumulation of point mutations. The amino acid H625R in combination with S50L may have a significant impact on the interaction between spike glycoprotein and ACE2.
A Strategic Framework of SARS‐CoV‐2 Genomic Surveillance in Bangladesh

Mohammad Jubair,Md. Mobarok Hossain,Mst. Noorjahan Begum,Shovan Basak Moon,Shahriar Islam,Md. Yeasir Karim,Sezanur Rahman,Manjur H. Khan,Mohammad Tanbir Habib,Tahmina Shirin,Firdausi Qadri,Mustafizur Rahman

DOI: https://doi.org/10.1111/irv.70019

2024-10-25

Influenza and Other Respiratory Viruses

Abstract:ABSTRACT Background The global pandemic caused by SARS‐CoV‐2 has underlined the significance of strict genomic surveillance to track virus evolution and the possible emergence of new variants, particularly in densely populated countries like Bangladesh. This study outlines a strategic framework of genomic surveillance to track the evolution of the virus in Bangladesh between June 2021 and December 2022 through the National SARS‐CoV‐2 Variant Surveillance (NSVS) program involving collaboration across 4 major institutes and 13 hospitals nationwide. Methods We aimed to capture the variants of SARS‐CoV‐2 throughout the country utilizing standardized procedures, modern sequencing technology, and stringent quality control, promoting data accuracy and the timely detection of new variants of concern. We sequenced over 2200 genomes, documenting the prevalence of the Delta variant initially, followed by the emergence of Omicron variants BA.1, BA.2, BA.5, and XBB, each affecting transmission rates and vaccine efficacy differently. Results The clinical manifestations of the variants differed, with some symptoms occurring more frequently in Delta cases and vice versa. Vaccinated individuals were more affected by Omicron cases compared to Delta cases. These variants were responsible for two major COVID‐19 waves in the country, each with significant clinical effects. Phylogenetic analyses placed the local SARS‐CoV‐2 variants within a global context, indicating the Delta variant likely entered from India and Omicron from Europe. Conclusion This research highlights the significance of collaborative surveillance strategies for guiding public health choices and the critical role of genomic analysis in monitoring virus evolution, shaping targeted pandemic responses. Bangladesh's contributions significantly enhance global insight into COVID‐19's genomic evolution.

infectious diseases,virology
Prevalence and diversity of imported severe acute respiratory syndrome coronavirus 2 variants in China, 2021–2022

Yenan Feng,Xiang Zhao,Zhixiao Chen,Yuchao Wu,Lili Li,Changcheng Wu,Kai Nie,Xiaoyu Yang,Peihua Niu,Ji Wang,Shiwen Wang,Cao Chen

DOI: https://doi.org/10.1002/jmv.29664

IF: 20.693

2024-05-11

Journal of Medical Virology

Abstract:The causative agent of coronavirus disease 2019 (COVID‐19), known as severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has spread accumulatively to 240 countries and continues to evolve. To gain a comprehensive understanding of the epidemiological characteristics of imported variants in China and their correlation with global circulating variants, genomic surveillance data from 11 139 imported COVID‐19 cases submitted by Chinese provincial CDC laboratories between 2021 and 2022 were analyzed. Consensus sequences underwent rigorous quality checks, followed by amino acid mutations analysis using Nextclade. Sequences with satisfactory quality control status were classified according to the Pango nomenclature. The results showed that the dominant variants in imported cases reflected the global epidemic trend. An increase in the number of imported SARS‐CoV‐2 lineages monitored in China in the second half of 2022, and the circulating Omicron subvariants changed from the ancestral lineages of BA.5 and BA.2 into the lineages containing key amino acid mutations of spike protein. There was significant variation in the detection of Omicron subvariants among continents (χ2 = 321.968, p

virology
The emergence, genomic diversity and global spread of SARS-CoV-2

Juan Li,Shengjie Lai,George F. Gao,Weifeng Shi

DOI: https://doi.org/10.1038/s41586-021-04188-6

IF: 64.8

2021-12-08

Nature

Abstract:Since the first cases of COVID-19 were documented in Wuhan, China in 2019, the world has witnessed a devastating global pandemic, with more than 238 million cases, nearly 5 million fatalities and the daily number of people infected increasing rapidly. Here we describe the currently available data on the emergence of the SARS-CoV-2 virus, the causative agent of COVID-19, outline the early viral spread in Wuhan and its transmission patterns in China and across the rest of the world, and highlight how genomic surveillance, together with other data such as those on human mobility, has helped to trace the spread and genetic variation of the virus and has also comprised a key element for the control of the pandemic. We pay particular attention to characterizing and describing the international spread of the major variants of concern of SARS-CoV-2 that were first identified in late 2020 and demonstrate that virus evolution has entered a new phase. More broadly, we highlight our currently limited understanding of coronavirus diversity in nature, the rapid spread of the virus and its variants in such an increasingly connected world, the reduced protection of vaccines, and the urgent need for coordinated global surveillance using genomic techniques. In summary, we provide important information for the prevention and control of both the ongoing COVID-19 pandemic and any new diseases that will inevitably emerge in the human population in future generations.

multidisciplinary sciences
Wastewater-based epidemiological surveillance of SARS-CoV-2 new variants BA.2.86 and offspring JN.1 in south and Southeast Asia

Dhammika Leshan Wannigama,Mohan Amarasiri,Phatthranit Phattharapornjaroen,Cameron Hurst,Charin Modchang,Sudarat Chadsuthi,Suparinthon Anupong,Kazuhiko Miyanaga,Longzhu Cui,W K C P Werawatte,S M Ali Hosseini Rad,Stefan Fernandez,Angkana T Huang,Porames Vatanaprasan,Thammakorn Saethang,Sirirat Luk-in,Robin James Storer,Puey Ounjai,Ratana Tacharoenmuang,Naveen Kumar Devanga Ragupathi,Phitsanuruk Kanthawee,Bernadina Cynthia,John Jefferson V Besa,Asada Leelahavanichkul,Talerngsak Kanjanabuch,Paul G Higgins,Asuka Nanbo,Anthony Kicic,Andrew C Singer,Tanittha Chatsuwan,Sam Trowsdale,Takashi Furukawa,Kazunari Sei,Daisuke Sano,Hitoshi Ishikawa,Kenji Shibuya,Aisha Khatib,Shuichi Abe,Parichart Hongsing

DOI: https://doi.org/10.1093/jtm/taae040

2024-03-04

Journal of Travel Medicine

Abstract:Discover the shifting landscape of SARS-CoV-2 variants from October to December 2023, with JN.1 dominating South and Southeast Asia wastewater samples, increasing from < 10% to over 90%. Experience the dynamic evolution of viral strains in this period.

medicine, general & internal,infectious diseases,public, environmental & occupational health
Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape

Fuxing Lou,Maochen Li,Zehan Pang,Lin Jiang,Lin Guan,Lili Tian,Jiaming Hu,Junfen Fan,Huahao Fan

DOI: https://doi.org/10.3389/fimmu.2021.744242

IF: 7.3

2021-11-05

Frontiers in Immunology

Abstract:The global pandemic of the coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), places a heavy burden on global public health. Four SARS-CoV-2 variants of concern including B.1.1.7, B.1.351, B.1.617.2, and P.1, and two variants of interest including C.37 and B.1.621 have been reported to have potential immune escape, and one or more mutations endow them with worrisome epidemiologic, immunologic, or pathogenic characteristics. This review introduces the latest research progress on SARS-CoV-2 variants of interest and concern, key mutation sites, and their effects on virus infectivity, mortality, and immune escape. Moreover, we compared the effects of various clinical SARS-CoV-2 vaccines and convalescent sera on epidemic variants, and evaluated the neutralizing capability of several antibodies on epidemic variants. In the end, SARS-CoV-2 evolution strategies in different transmission stages, the impact of different vaccination strategies on SARS-CoV-2 immune escape, antibody therapy strategies and COVID-19 epidemic control prospects are discussed. This review will provide a systematic and comprehensive understanding of the secret of SARS-CoV-2 variants of interest/concern and immune escape.

immunology
Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron XBB and JN.1 Lineages — United States, May 2023–September 2024

Kevin C. Ma,Juan Castro,Anastasia S. Lambrou,Erica Billig Rose,Peter W. Cook,Dhwani Batra,Caelin Cubenas,Laura J. Hughes,Duncan R. MacCannell,Paritra Mandal,Neha Mittal,Mili Sheth,Casey Smith,Amber Winn,Aron J. Hall,David E. Wentworth,Benjamin J. Silk,Natalie J. Thornburg,Clinton R. Paden

DOI: https://doi.org/10.15585/mmwr.mm7342a1

2024-10-25

MMWR Morbidity and Mortality Weekly Report

Abstract:This report summarizes U.S. trends in variant proportion estimates during May 2023–September 2024, a period when SARS-CoV-2 lineages primarily comprised descendants of Omicron variants XBB and JN.1

public, environmental & occupational health
Emergence of New SARS-CoV2 Omicron Variants after the Change of Surveillance and Control Strategy

José María González Alba,Zulema Pérez-Martínez,José A. Boga,Susana Rojo-Alba,Juan Gómez de Oña,Marta E. Alvarez-Argüelles,Garbriel Martín Rodríguez,Isabel Costales Gonzalez,Ismael Huerta González,Eliecer Coto,Santiago Melón García

DOI: https://doi.org/10.3390/microorganisms10101954

IF: 4.5

2022-09-30

Microorganisms

Abstract:In January 2022, there was a global and rapid surge of the Omicron variant of SARS-CoV-2 related to more transmission. This coincided with an increase in the incidence in Asturias, a region where rapid diagnosis and containment measures had limited the circulation of variants. Methods: From January to June 2022, 34,591 variants were determined by the SNP method. From them, 445 were characterized by the WGS method and classified following pangolin program and phylogenic analysis. Results: The Omicron variant went from being detected in 2438 (78%) samples in the first week of January 2021 to 4074 (98%) in the third week, according to the SNP method. Using the WGS method, 159 BA.1 (35.7%), 256 BA.2 (57.6%), 1 BA.4 (0.2%) and 10 BA.5 (2.2%) Omicron variants were found. Phylogenetic analysis detected that three new sub-clades, BA.2,3.5, BA.2.56 and BF1, were circulating. Conclusions: The increase in the incidence of SARS-CoV2 caused the circulation of new emerging variants. Viral evolution calls for continuous genomic surveillance.

microbiology
In silico genomic surveillance by CoVerage predicts and characterizes SARS-CoV-2 Variants of Interest

Katrina Norwood,Zhi-Luo Deng,Susanne Reimering,Gary Robertson,Mohammad-Hadi Foroughmand-Araabi,Sama Goliaei,Martin Hoelzer,Alice Carolyn McHardy

DOI: https://doi.org/10.1101/2024.03.07.583829

2024-10-22

Abstract:Rapidly evolving viral pathogens such as SARS-CoV-2 continuously accumulate amino acid changes, some of which affect transmissibility, virulence or improve the virus' ability to escape host immunity. Since the beginning of the pandemic and establishment of SARS-CoV-2 as a human pathogen, multiple lineages with concerning phenotypic alterations, so called Variants of Concern (VOCs), have emerged and risen to predominance. To optimize public health management and to ensure the continued efficacy of vaccines, the early detection of such variants of interest is essential. Therefore, large-scale viral genomic surveillance programs have been initiated worldwide, with data being deposited in public repositories in a timely manner. However, technologies for their continuous interpretation are currently lacking. Here, we describe the CoVerage system (www.sarscoverage.org) for viral genomic surveillance, which continuously predicts and characterizes novel and emerging potential Variants of Interest (pVOIs) from country-wise lineage frequency dynamics together with their antigenic and evolutionary alterations utilizing the GISAID viral genome resource. In a comprehensive assessment of VOIs, VOCs and VUMs identified, we demonstrate how CoVerage can be used to swiftly identify and characterize such variants, with a lead time of almost three months relative to them reaching their maximal abundances. CoVerage can facilitate the timely identification and assessment of future SARS-CoV-2 variants relevant for public health.

Bioinformatics
Systematic Genomic Surveillance of SARS-CoV-2 at Xiamen International Airport and the Port of Xiamen Reveals the Importance of Incoming Travelers in Lineage Diversity

Ruiluan You,Ruotong Wu,Xijing Wang,Rao Fu,Ningshao Xia,Yixin Chen,Kunyu Yang,Junyu Chen

DOI: https://doi.org/10.3390/v16010132

2024-01-17

Viruses

Abstract:Sever Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is still a threat to human health globally despite the World Health Organization (WHO) announcing the end of the COVID-19 pandemic. Continued surveillance of SARS-CoV-2 at national borders would be helpful in understanding the epidemics of novel imported variants and updating local strategies for disease prevention and treatment. This study focuses on the surveillance of imported SARS-CoV-2 variants among travelers entering Xiamen International Airport and the Port of Xiamen from February to August 2023. A total of 97 imported SARS-CoV-2 sequences among travelers from 223 cases collected from 12 different countries and regions were identified by real-time RT-PCR. Next-generation sequencing was used to generate high-quality complete sequences for phylogenetic and population dynamic analysis. The study revealed a dominant shift in variant distribution, in which the XBB subvariant (XBB.1.5, XBB.1.16, XBB.1.9, XBB.2.3, and EG.5.1) accounted for approximately 88.8% of the sequenced samples. In detail, clades 23D and 23E accounted for 26.2% and 21.4% of the sequenced samples, respectively, while clades 23B (13.6%) and 23F (10.7%) took the third and fourth spots in the order of imported sequences, respectively. Additionally, the XBB.2.3 variants were first identified in imported cases from the mainland of Xiamen, China on 27 February 2023. The spatiotemporal analyses of recent viral genome sequences from a limited number of travelers into Xiamen provide valuable insights into the situation surrounding SARS-CoV-2 and highlight the importance of sentinel surveillance of SARS-CoV-2 variants in the national border screening of incoming travelers, which serves as an early warning system for the presence of highly transmissible circulating SARS-CoV-2 lineages.

virology
The biological and clinical significance of emerging SARS-CoV-2 variants

Kaiming Tao,Philip L. Tzou,Janin Nouhin,Ravindra K. Gupta,Tulio de Oliveira,Sergei L. Kosakovsky Pond,Daniela Fera,Robert W. Shafer

DOI: https://doi.org/10.1038/s41576-021-00408-x

IF: 59.581

2021-09-17

Nature Reviews Genetics

Abstract:Nature Reviews Genetics, Published online: 17 September 2021; doi:10.1038/s41576-021-00408-xIn this Review, the authors describe our latest understanding of the emergence and properties of SARS-CoV-2 genetic variants, particularly those designated as WHO (World Health Organization) 'variants of concern'. They focus on the consequences of these variants for antibody-mediated virus neutralization, with important implications for reinfection risk and for vaccine effectiveness.

genetics & heredity
Tracking the prevalence and emergence of SARS-CoV-2 variants of concern using a regional genomic surveillance program

Ana Jung,Lindsay Droit,Binita Febles,Catarina Fronick,Lisa Cook,Scott A. Handley,Bijal A. Parikh,David Wang

DOI: https://doi.org/10.1128/spectrum.04225-23

IF: 3.7

2024-06-25

Microbiology Spectrum

Abstract:ABSTRACT SARS-CoV-2 molecular testing coupled with whole-genome sequencing is instrumental for real-time genomic surveillance. Genomic surveillance is critical for monitoring the spread of variants of concern (VOCs) as well as discovery of novel variants. Since the beginning of the pandemic, millions of SARS-CoV-2 genomes have been deposited into public sequence databases. This is the result of efforts of both national and regional diagnostic laboratories. In this study, we describe the results of SARS-CoV-2 genomic surveillance from February 2021 to June 2022 at a metropolitan hospital in the United States. We demonstrate that consistent daily sampling is sufficient to track the regional prevalence and emergence of VOCs and recapitulate national trends. Similar sampling efforts should be considered a viable option for local SARS-CoV-2 genomic surveillance at other regional laboratories. IMPORTANCE In our manuscript, we describe the results of SARS-CoV-2 genomic surveillance from February 2021 to June 2022 at a metropolitan hospital in the United States. We demonstrate that consistent daily sampling is sufficient to track the regional prevalence and emergence of variants of concern (VOCs). Similar sampling efforts should be considered a viable option for local SARS-CoV-2 genomic surveillance at other regional laboratories. While the SARS-CoV-2 pandemic has evolved into a more endemic form, we still believe that additional real-world information about sampling, procedures, and data interpretation is valuable for ongoing as well as future genomic surveillance efforts. Our study should be of substantial interest to clinical virologists.

microbiology
COVID-19 pandemic - Cocktail of variants, a study from Northern India

Preeti Chaudhary,Neelam Gulati,Varsha Gupta,Rajni Garg,Sohini Walia,Isha Dhawan,Bhuwaneshwar Thakur

DOI: https://doi.org/10.4103/jfmpc.jfmpc_1107_23

Abstract:Context: The aim of the study was to identify and monitor the circulating strains of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the samples received at our center and update the existing national and international genomic surveillance data. Introduction: SARS-CoV-2 is no exception to the basic nature of the viruses ability to change and evolve. Since its first report in December 2019 from Wuhan, China, multiple variants of the virus have emerged and been reported. Five variants of concern have been recognized and reported by the Centers for Disease Control and Prevention, which are associated with variable degrees of transmissibility and mortality. Materials and methods: Nasopharyngeal and oropharyngeal swabs received in viral transport medium at the Viral Research Diagnostic Laboratory were processed for reverse transcription-polymerase chain reaction for SARS-CoV-2. Whole genome sequencing (WGS) was performed for selective positive samples using Oxford Nanopore sequencing technology, using MinKNOW software for data acquisition. Statistical analysis: The clades were assigned using Nextclade v2.4.1 software. The statistical analysis was calculated using OpenEpi version 3, an open-source calculator, and two by two. Results: Variants reported over the study period included Alpha, Kappa, Delta, and Omicron. Delta dominated in the year 2021, while Omicron was the dominant variant in 2022. In both the dominant variants, asymptomatics contributed to around 30-40% of positives. Intensive care unit admissions and mortality were higher in the Delta variant, while vaccination history and travel history were higher in the patients with Omicron variant. Conclusion: The trend tracking of these variants has been important in view of public health, enabling early interventions to control the spread of the disease and foresight in preparation for the situation.

Global surveillance of emerging SARS-CoV-2 variants

Early Detection and Surveillance of the SARS-CoV-2 Variant BA.2.86 — Worldwide, July–October 2023

Global landscape of SARS-CoV-2 genomic surveillance and data sharing

Genomic Surveillance for SARS-CoV-2 — China, September 26, 2022 to January 29, 2023

Corrigendum To: Genomic Diversity of Severe Acute Respiratory Syndrome–Coronavirus 2 in Patients with Coronavirus Disease 2019

Landscape of SARS-CoV-2 genomic surveillance, public availability extent of genomic data, and epidemic shaped by variants: a global descriptive study

COVID-19: Understanding the New Variants of Concern

Global Landscape of SARS-CoV-2 Genomic Surveillance, Public Availability Extent of Genomic Data, and Epidemic Shaped by Variants.

Genomic epidemiology reveals early transmission of SARS-CoV-2 and mutational dynamics in Nanning, China

A Strategic Framework of SARS‐CoV‐2 Genomic Surveillance in Bangladesh

Prevalence and diversity of imported severe acute respiratory syndrome coronavirus 2 variants in China, 2021–2022

The emergence, genomic diversity and global spread of SARS-CoV-2

Wastewater-based epidemiological surveillance of SARS-CoV-2 new variants BA.2.86 and offspring JN.1 in south and Southeast Asia

Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape

Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron XBB and JN.1 Lineages — United States, May 2023–September 2024

Emergence of New SARS-CoV2 Omicron Variants after the Change of Surveillance and Control Strategy

In silico genomic surveillance by CoVerage predicts and characterizes SARS-CoV-2 Variants of Interest

Systematic Genomic Surveillance of SARS-CoV-2 at Xiamen International Airport and the Port of Xiamen Reveals the Importance of Incoming Travelers in Lineage Diversity

The biological and clinical significance of emerging SARS-CoV-2 variants

Tracking the prevalence and emergence of SARS-CoV-2 variants of concern using a regional genomic surveillance program

COVID-19 pandemic - Cocktail of variants, a study from Northern India